[
  {
    "ts": "2025-12-15T13:49:31+00:00",
    "headline": "Stock Market Today: Dow Rises As Nvidia Rebounds; Tesla Near Buy Point (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index rose Monday as Nvidia stock rebounded in morning trading. Tesla raced higher, nearing a buy point.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-nvidia-nvda-stock-tesla-tsla-stock-buy-point/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "cf529e2c-91e5-3c11-aaf1-81cac2b85ab4",
      "content": {
        "id": "cf529e2c-91e5-3c11-aaf1-81cac2b85ab4",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Rises As Nvidia Rebounds; Tesla Near Buy Point (Live Coverage)",
        "description": "",
        "summary": "Stock Market Today: The Dow Jones index rose Monday as Nvidia stock rebounded in morning trading. Tesla raced higher, nearing a buy point.",
        "pubDate": "2025-12-15T13:49:31Z",
        "displayTime": "2025-12-15T13:49:31Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cf529e2c-91e5-3c11-aaf1-81cac2b85ab4/stock-market-today-dow-rises.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b93082b62d669a716dcee1724ff49dd4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.W.gVKPZAUsCdjxUqdHj9g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b93082b62d669a716dcee1724ff49dd4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2hRxUEO7176T7wyZJrSKZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b93082b62d669a716dcee1724ff49dd4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-nvidia-nvda-stock-tesla-tsla-stock-buy-point/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "QQQ"
            },
            {
              "symbol": "SPY"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T16:14:05+00:00",
    "headline": "Merck Poised for Mid-Single-Digit Revenue Growth in Fiscal 2026, BofA Says",
    "summary": "Merck (MRK) is expected to deliver mid-single-digit revenue growth in fiscal 2026 driven primarily b",
    "url": "https://finance.yahoo.com/news/merck-poised-mid-single-digit-161405930.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "6cda9153-03d4-3ed6-af60-779bd1865581",
      "content": {
        "id": "6cda9153-03d4-3ed6-af60-779bd1865581",
        "contentType": "STORY",
        "title": "Merck Poised for Mid-Single-Digit Revenue Growth in Fiscal 2026, BofA Says",
        "description": "",
        "summary": "Merck (MRK) is expected to deliver mid-single-digit revenue growth in fiscal 2026 driven primarily b",
        "pubDate": "2025-12-15T16:14:05Z",
        "displayTime": "2025-12-15T16:14:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-poised-mid-single-digit-161405930.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-poised-mid-single-digit-161405930.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CDTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T14:32:00+00:00",
    "headline": "BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock?",
    "summary": "BMY shares are rebounding after a strong Q3, lifted by rising demand for Opdivo, Reblozyl and Camzyos, even as legacy drugs face generic pressure.",
    "url": "https://finance.yahoo.com/news/bmy-gains-13-1-three-143200977.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2e629536-ee93-3503-a21e-fed55cffbab0",
      "content": {
        "id": "2e629536-ee93-3503-a21e-fed55cffbab0",
        "contentType": "STORY",
        "title": "BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "BMY shares are rebounding after a strong Q3, lifted by rising demand for Opdivo, Reblozyl and Camzyos, even as legacy drugs face generic pressure.",
        "pubDate": "2025-12-15T14:32:00Z",
        "displayTime": "2025-12-15T14:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-gains-13-1-three-143200977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-gains-13-1-three-143200977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T11:04:00+00:00",
    "headline": "LGND: 2025 Analyst Day",
    "summary": "By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) held its 2025 analyst day on December 9 th , 2025, at the Harvard Club in New York City. The morning presentations highlighted the company’s achievements for 2025 and looked ahead to 2026, providing financial guidance for the next year. Details of the event are included in a press",
    "url": "https://finance.yahoo.com/news/lgnd-2025-analyst-day-110400446.html",
    "source": "Zacks Small Cap Research",
    "provider": "yfinance",
    "raw": {
      "id": "395adabc-a250-39d3-8f9e-e7066bff1c8b",
      "content": {
        "id": "395adabc-a250-39d3-8f9e-e7066bff1c8b",
        "contentType": "STORY",
        "title": "LGND: 2025 Analyst Day",
        "description": "",
        "summary": "By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) held its 2025 analyst day on December 9 th , 2025, at the Harvard Club in New York City. The morning presentations highlighted the company’s achievements for 2025 and looked ahead to 2026, providing financial guidance for the next year. Details of the event are included in a press",
        "pubDate": "2025-12-15T11:04:00Z",
        "displayTime": "2025-12-15T11:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/scr.zacks.com/cbf2a74c5173cb30d218a99e4e433c9a",
          "originalWidth": 1382,
          "originalHeight": 682,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LNP1WeqP9zeD0QyjHK9gKw--~B/aD02ODI7dz0xMzgyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/cbf2a74c5173cb30d218a99e4e433c9a.cf.webp",
              "width": 1382,
              "height": 682,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hqlrHQOrOoS9rRPj2wsqEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/cbf2a74c5173cb30d218a99e4e433c9a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks Small Cap Research",
          "url": "http://scr.zacks.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lgnd-2025-analyst-day-110400446.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lgnd-2025-analyst-day-110400446.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LGND"
            },
            {
              "symbol": "CHRO"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T14:50:00+00:00",
    "headline": "MRK Gets Positive CHMP Opinion for Expanded Use of Winrevair in PAH",
    "summary": "Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients across WHO FC II-IV.",
    "url": "https://finance.yahoo.com/news/mrk-gets-positive-chmp-opinion-145000734.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "78130ff9-d5b8-3c75-93c4-80a489f27720",
      "content": {
        "id": "78130ff9-d5b8-3c75-93c4-80a489f27720",
        "contentType": "STORY",
        "title": "MRK Gets Positive CHMP Opinion for Expanded Use of Winrevair in PAH",
        "description": "",
        "summary": "Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients across WHO FC II-IV.",
        "pubDate": "2025-12-15T14:50:00Z",
        "displayTime": "2025-12-15T14:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EfDoN3QVRYGCfRDweFAACw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwDxubmjtiCRyiYBqVh9AQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrk-gets-positive-chmp-opinion-145000734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrk-gets-positive-chmp-opinion-145000734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T05:01:00+00:00",
    "headline": "Biotech Bill Bundled in Pentagon Spending Plan May Worsen Pharma’s Patent Cliff Dilemma",
    "summary": "The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf courses.",
    "url": "https://www.thedailyupside.com/industries/healthcare/biotech-bill-bundled-in-massive-pentagon-spending-plan-could-remake-pharmas-approach-to-its-big-patent-cliff/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "2e68b0de-307d-312d-9893-7bc06417b39d",
      "content": {
        "id": "2e68b0de-307d-312d-9893-7bc06417b39d",
        "contentType": "STORY",
        "title": "Biotech Bill Bundled in Pentagon Spending Plan May Worsen Pharma’s Patent Cliff Dilemma",
        "description": "",
        "summary": "The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf courses.",
        "pubDate": "2025-12-15T05:01:00Z",
        "displayTime": "2025-12-15T05:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/6ae3d65b1c8f3c1c56026721fe1ba620",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Photo of the US Capitol building.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IfwtQAEMc3Kt4LfmZbtciA--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/6ae3d65b1c8f3c1c56026721fe1ba620.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0F2Yd31x4QEo7Zd.MnYX7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/6ae3d65b1c8f3c1c56026721fe1ba620.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/biotech-bill-bundled-in-massive-pentagon-spending-plan-could-remake-pharmas-approach-to-its-big-patent-cliff/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biotech-bill-bundled-pentagon-spending-050100249.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]